Home LiteratureArticle Details
PMID: 17013901 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.

International journal of cancer ·Vol. 120 ·No. 1 ·2007-01-01 ·Pages 81-90

Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF, Johanning GL

Abstract

Individual classes of human endogenous retrovirus (HERV) genes and proteins are expressed in cancer, but expression of more than one type of HERV is rare. We report here the expression of multiple HERV genes and proteins in ovarian cell lines and tissues. Expression of HERV-K env mRNA was greater in ovarian epithelial tumors than in normal ovarian tissues (N = 254). The expression of this protein on the surface and in the cytoplasm of ovarian cancer cells was confirmed using anti-HERV-K specific antibody by flow cytometric analysis. The frequency of expression of HERV-K env protein in multitissue microarrays (N = 641) was determined by immunohistochemistry and a significant correlation with tumor histotype was found. A significantly increased expression of HERV-K was observed in tumors with low malignant potential and low grade, relative to expression in normal ovarian tissues. The increase in expression of HERV-K env protein took place in a stepwise fashion in serous papillary adenocarcinoma. Interestingly, we found that other classes of HERV env mRNAs, including ERV3 and HERV-E, are expressed in the same ovarian cancer tissues that expressed HERV-K. Furthermore, anti-HERV antibodies including anti-ERV3 (30%), anti-HERV-E (40%) and anti-HERV-K (55%) were detected in patients with ovarian cancer, but not in normal female controls. HERV env proteins are frequently transcribed and translated in ovarian epithelial tumors, and multiple HERV families are detectable in ovarian cancer. HERV env proteins, and especially those expressed on the cell surface, may serve as novel tumor targets for detection, diagnosis and immunotherapy of ovarian cancer.

MeSH Terms
Adenocarcinoma, Clear Cell/metabolism,virology Adenocarcinoma, Mucinous/metabolism,virology Adult Aged Aged, 80 and over Amino Acid Sequence Base Sequence Carcinoma, Endometrioid/metabolism,virology Case-Control Studies Cystadenocarcinoma, Serous/metabolism,virology Endogenous Retroviruses/genetics,immunology,metabolism Enzyme-Linked Immunosorbent Assay Female Flow Cytometry Fluorescent Antibody Technique Gene Products, env/genetics,metabolism,physiology Humans Immunoenzyme Techniques Membrane Proteins/genetics,metabolism Middle Aged Molecular Sequence Data Ovarian Neoplasms/metabolism,virology Ovary/metabolism RNA, Messenger/genetics,metabolism Reverse Transcriptase Polymerase Chain Reaction Tissue Array Analysis Tumor Cells, Cultured
Chemicals
Gene Products, env Membrane Proteins Np9 protein, HERV-K, human RNA, Messenger
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Wang-Johanning Feng
Department of Veterinary Sciences and Michale E. Keeling Center for Comparative Medicine and Research, University of Texas MD Anderson Cancer Center, Houston, TX 78602, USA. fwangjoh@mdanderson.org
Liu Jinsong
Rycaj Kiera
Huang Miao
Tsai Kate
Rosen Daniel G
Chen Dung-Tsa
Lu Danielle W
Barnhart Kirstin F
Johanning Gary L
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
2007-01-01
Pages
81-90
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com